Piper Sandler Reiterates Overweight on OPKO Health, Raises Price Target to $4

Piper Sandler analyst Edward Tenthoff has reiterated an Overweight rating on OPKO Health (NASDAQ: OPK) and raised the price target from $3 to $4. This adjustment reflects a positive outlook for the company in the market.